PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21273576-0	2011	Measuring IGF-1, ER-alpha and EGFR expression can predict tamoxifen-resistance in ER-positive breast cancer.	Tamoxifen	58-67	epidermal growth factor receptor	Homo sapiens	30-34	
21273576-1	2011	In vitro studies have suggested that tamoxifen resistance may be due to altered expression and downstream signalling of insulin-like growth factor-1 (IGF-1) receptor (IGF-1l), oestrogen receptor-alpha (ERalpha), epidermal growth factor receptor (EGFR) and HER-2.	Tamoxifen	37-46	epidermal growth factor receptor	Homo sapiens	212-244	
21273576-1	2011	In vitro studies have suggested that tamoxifen resistance may be due to altered expression and downstream signalling of insulin-like growth factor-1 (IGF-1) receptor (IGF-1l), oestrogen receptor-alpha (ERalpha), epidermal growth factor receptor (EGFR) and HER-2.	Tamoxifen	37-46	epidermal growth factor receptor	Homo sapiens	246-250	
21273576-9	2011	ERalpha inversely correlated with EGFR expression in the tamoxifen resistant group only.	Tamoxifen	57-66	epidermal growth factor receptor	Homo sapiens	34-38